Avenue Therapeutics, Inc. (ATXI): Price and Financial Metrics

Avenue Therapeutics, Inc. (ATXI): $0.21

0.08 (-26.59%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

ATXI Price/Volume Stats

Current price $0.21 52-week high $3.93
Prev. close $0.28 52-week low $0.17
Day low $0.20 Volume 2,300
Day high $0.24 Avg. volume 237,459
50-day MA $0.24 Dividend yield N/A
200-day MA $1.41 Market Cap 662.70K

ATXI Stock Price Chart Interactive Chart >


Avenue Therapeutics, Inc. (ATXI) Company Bio


Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes an intravenous formulation of tramadol HCI principally for use in the acute/intensive care hospital setting. Its product candidate is IV Tramadol for the treatment of post-operative pain. The company was founded in 2015 and is based in New York, New York.


ATXI Latest News Stream


Event/Time News Detail
Loading, please wait...

ATXI Latest Social Stream


Loading social stream, please wait...

View Full ATXI Social Stream

ATXI Price Returns

1-mo -16.00%
3-mo -73.42%
6-mo -87.93%
1-year -94.34%
3-year -99.93%
5-year -100.00%
YTD -89.50%
2024 -83.44%
2023 -86.12%
2022 -91.48%
2021 -84.74%
2020 -38.02%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!